Abstract Effective intervention and detection of developmental disabilities (DDs) should be carried out early and accurately. This paper discusses a novel AI-based approach for detecting DDs precisely, by incorporating both speech and behavioral data in a unique manner. The new architecture comprises several key stages, with innovations attributed to the system: Enhanced Gaussian-Based Noise Filtering (EGNF) is used to enhance speech; Conv-BiLSTM and Transformer Embeddings for performing strong feature extraction from speech and behavior; Harmony-ReliefF Optimization (HRO) for feature selection, and BioNeuroFusionNet (BNFN) as a novel classification network integrating IndRNN and MnasNet, with GNA selected as the class superiors. The Harmony-ReliefF Optimization (HRO) strategy combines the exploration capabilities of the Harmony Search Algorithm (HSA) with the feature ranking ability of ReliefF for optimizing the feature space. The features selected and optimally extracted are then fed into the novel BioNeuroFusionNet (BNFN) intended for final classification. The BNFN is another significant contribution of this work, where Independently Recurrent Neural Networks (IndRNN) are incorporated for fast processing of sequential data set and MnasNet (MN) for extracting high-level abstract features. The experimental result indicates that this integrated architecture works effectively with high accuracy (0.98942 for voice; 0.99632 for behavior) and very high scores in precision, recall, specificity, and other relevant metrics. Indeed, these results indicate that the system proposed in this work represents a considerable improvement in the area of early diagnosis and intervention of developmental disorders.
Introduction: Diabetic retinopathy (DR) is an inflammatory condition affecting the retina caused by elevated and unregulated blood glucose levels. On a global scale, it is a contributing factor to vision impairment. Several deep learning (DL) methods use retinal images to identify DR severity. However, a significant improvement is required to assist medical professionals in recognizing DR in its early phases. Methods: Thus, the author introduced a method based on the DL technique to determine the DR severity grades using retinal images. A ShuffleNet V2 model with vision transformers' (ViT) attention mechanism was used to extract the features. An improved Whale optimization method (IWO) was used to fine-tune the feature extraction model. We employed a convolutional Kolmogorov-Arnold Network to categorize the DR severity using the extracted features. The EyePACS dataset was utilized to train the proposed DR severity grading model using a five-fold cross-validation strategy. We generalized the model on the Messidor-2 dataset. Results: The findings revealed an average accuracy of 93.84% on the MESSIDOR-2 dataset, demonstrating a substantial improvement in detecting DR using the fundus images. Discussion: Furthermore, the model demands minimal processing resources to generate the outcomes, leading to the deployment of the proposed DR severity detection model in healthcare facilities with limited computational resources.
Early and precise recognition of developmental disabilities (DDs) is essential for the timely intervention of preschool-age children. Although various predictive models have been developed in the past, they cannot provide accurate detections and face challenges like high false prediction, limited generalization, etc. To address these issues, a novel artificial intelligence (AI)-based algorithm was proposed for accurate DD detection. The proposed system integrates digital biomarkers from speech and behavioral domains for predicting DDs. Consequently, an Enhanced Gaussian-Based Noise Filtering (EGNF) is applied to speech data, and Z-score normalization is applied to behavioral data for preprocessing, which makes the raw data reliable for subsequent analysis. Further, feature extraction is performed using Convolutional-Bidirectional Long Short-Term Memory (Conv-BiLSTM) for speech data and Graph Attention Network (GAT) for behavioral data. Subsequently, a Hybrid Feature Selection (HFS) method was developed by combining the Harmony Search Algorithm (HSA) and ReliefF ranking for selecting informative and relevant attributes for model training. Finally, a hybrid classification model named DeepSTNet has been developed by integrating MnasNet and Independently Recurrent Neural Networks (IndRNN), which allows the capture of spatial and temporal long-term dependencies within the data, resulting in high detection performances. The proposed framework was implemented in Python and validated using comprehensive data formed by combining the Dysarthria Detection dataset and the Autism Dataset for Toddlers. The execution outcomes highlighted that the developed framework achieved an accuracy of 99.46%, a precision of 97.74%, and a recall of 98.05%, illustrating that this AI-centric system can be equipped by end users, including healthcare professionals and caregivers, with tools for early screening and detection of DDs.
PURPOSE: The earlier prediction of autism spectrum disorder (ASD) placed a serious attention on ensuring the appropriate intervention to improve the child's behavioral, cognitive, and social development. The previous detection process is commonly time-intensive, subjective, and highly dependent on the clinical professions, which leads to limited accessibility in rural areas. The difficulties are addressed by introducing effective ASD detection systems, which provide a scalable, objective, and fast solution, reducing the challenges in the healthcare environment. METHOD: This work integrates the Glowworm Optimization with Extreme Learning Machine Networks (GO-ELMN) model to enhance the efficiency of ASD prediction. During the analysis, ASD screening data for children are collected and processed frequently to obtain behavioral, demographic, and medical features. The extracted features are processed by an extraction learning technique, in which the network hyperparameters are optimized using the glowworm optimization algorithm. The optimized classifier recognizes children's behavior by addressing the issues of limited and imbalanced data. FINDINGS: The efficiency of the system is evaluated using experimental results, in which the system ensures high accuracy and convergence speed. CONCLUSION: The ASD detection model provides an interpretable, fast, and reliable solution that is effectively utilized in the pediatric healthcare domain.
Digital Health · مجلد 12 · 20552076261418837-20552076261418837
Objectives: Brain tumors have been a major factor in the development of mental disorders like anxiety and depression. The primary target of this research is to develop a smart, economically feasible system that can detect and classify brain tumors by analyzing MRI images, reducing manual labor, and shortening diagnostic time. Methods: Although diagnosis with medical imaging is efficient for various health issues, accurately classifying brain tumors remains challenging for medical experts. This research introduces a new energy channel-based hybrid optimized network (ECHO-Net) as an automatic identification tool for brain tumors, aiming to facilitate medical diagnosis remotely. Energy shape prior segmentation (ESPS) is part of the framework, providing accurate segmentation and cropping of tumor regions from MRIs. Channel and spatial attention-based neural network (CSA-Net) differentiates between normal and tumor-affected images. Additionally, the hybrid chimp-based whale optimization (HCWO) algorithm enhances prediction precision and optimally sets sigmoid activation function parameters for better convergence and generalization. Results: Performance evaluation of ECHO-Net using publicly available MRI brain datasets, including Figshare, BRATS 2018-2020, and a clinical MRI dataset, shows a peak signal-to-noise ratio of 41.87 dB, a Structural Similarity Index Measure of 0.992, a sensitivity of 99.4%, an accuracy of 99.2%, and an average computational time of 2.68 s, outperforming current state-of-the-art methods. Conclusion: The proposed ECHO-Net is an automated, accurate, fast, and robust system for brain tumor detection. With low computational costs, it effectively segments abnormal regions and recognizes tumor types, demonstrating strong potential as a tool in intelligent healthcare systems and real-world clinical applications.
brain tumor detectionbrain tumor segmentationMRI imageschannel and spatial attention
Rifaximin, a minimally absorbed broad-spectrum oral antibiotic, is used to target gut dysbiosis in patients with irritable bowel syndrome (IBS).However, conflicting trial data and methodological heterogeneity necessitate an updated, rigorous synthesis of its efficacy and safety profile.We conducted a systematic review and meta-analysis of randomized controlled trials (RCTs) comparing rifaximin with placebo in adult patients with IBS, adhering to the Preferred Reporting Items for Systematic reviews and Meta-Analyses (PRISMA) 2020 guidelines.The primary outcome was global symptom relief at the end of the treatment.Data were pooled using inverse-variance random-effects models with Hartung-Knapp-Sidik-Jonkman (HKSJ) adjustment.Evidence robustness was evaluated using prediction intervals (PI), Trial Sequential Analysis (TSA), trim-and-fill algorithms for publication bias, and the Grading of Recommendations, Assessment, Development, and Evaluation (GRADE) methodology.Nine RCTs (yielding 10 randomized comparisons due to one trial's a priori stratification by small intestinal bacterial overgrowth status) were included in this review.For the primary outcome (eight comparisons, N=2,056), rifaximin significantly improved global symptom relief compared to placebo (RR 1.54, 95% CI 1.13 to 2.11; p=0.014), corresponding to a number needed to treat for benefit (NNTB) of 6.However, statistical heterogeneity was substantial (I 2 =59.5%), and the 95% PI crossed the line of no effect (0.89-2.67).The primary effect lost statistical significance upon the exclusion of high-risk-of-bias trials (RR 1.47, 95% CI 0.95-2.27)and after adjusting for publication bias using the trim-and-fill method (RR 1.37, 95% CI 0.93-2.01).The TSA indicated that the accrued information size remained inconclusive for a conservative 15% relative benefit.Rifaximin demonstrated no statistically detectable difference in adverse events compared to placebo, though this is accompanied by considerable uncertainty (Peto OR 0.89 (95% CI 0.65-1.22)).Rifaximin demonstrates a modest overall benefit for global IBS symptoms and an excellent safety profile; however, the certainty of evidence is very low.The apparent efficacy is highly fragile, driven largely by industry-funded trials, undermined by publication bias, and characterized by wide prediction intervals.Biomarker-guided stratification, such as testing for small intestinal bacterial overgrowth (SIBO), may be required to optimize patient selection in future independent trials.
Bulletin of the World Health Organization · مجلد 104 (08) · 573-578
Problem: Traditional epidemiological surveillance methods are often limited by delays in reporting and fragmented data systems. Saudi Arabia faces additional public health challenges from mass gatherings during Hajj and Umrah, an increasing burden of noncommunicable diseases and rapid urbanization, highlighting the need for investing in digital epidemiology. Approach: Saudi Arabia has accelerated digital transformation in health care through Vision 2030 initiatives. The strategies include health information exchange platforms, analytics driven by artificial intelligence, telemedicine services and digital monitoring systems used during Hajj. We review current initiatives to invest in digital epidemiology in Saudi Arabia, implementation challenges and policy priorities. Local setting: Saudi Arabia's health system operates under a predominantly public model. The health ministry is the main provider, regulator and finance provider of most health-care services. Health-care coverage is nearly universal, with citizens receiving services free of charge through the public system. Ongoing reforms aim to gradually decentralize certain functions. Relevant changes: The initiatives under Vision 2030 have supported disease surveillance, data integration and public health response capacities. Existing digital health reforms have created a foundation for integrating digital epidemiology into routine public health practice. However, challenges remain, including fragmented interoperability between institutions, workforce shortages, unequal digital access, and concerns about data governance, privacy and algorithmic bias. Lessons learnt: Saudi Arabia's experience suggests that digital epidemiology is more effective when integrated within broader digital health reforms. Successful implementation requires not only digital infrastructure, but also workforce development, ethical governance, transparency and mechanisms for integrating digital data into public health decision-making.
digital epidemiologySaudi Vision 2030digitalization of healthcaredisease surveillance
American Journal of Pediatrics · مجلد 12 (3) · 87-102
Background: Parapneumonic effusion (PPE) and empyema remain serious complications of childhood pneumonia associated with significant morbidity despite advances in antimicrobial therapy and surgical techniques. Accurate disease staging and timely stage-directed intervention are fundamental to optimal outcomes. Objective: To provide a current, evidence-based synthesis of the definition, etiology, diagnosis, and management of complicated pneumonia in children, with particular focus on areas of ongoing clinical controversy. Methods: A narrative review incorporating randomized controlled trials, systematic reviews, meta-analyses, Cochrane reviews, and international clinical guidelines published between 2016 and 2026 was conducted. PubMed was searched through May 2026 using terms including pneumonia, complicated pneumonia, parapneumonic effusion, empyema, VATS, fibrinolysis, decortication, and pediatric. Results: Chest radiography remains the initial imaging modality for suspected complicated pneumonia, with lateral decubitus views needed to assess pleural fluid mobility. However, chest ultrasonography is the preferred imaging modality for evaluating parapneumonic effusions and empyema because of its superior diagnostic accuracy, ability to characterize pleural collections, and absence of ionizing radiation. Management is stage-dependent, combining targeted antibiotic therapy with procedural intervention when indicated. Image-guided pigtail catheter drainage with intrapleural fibrinolytic therapy is effective for most patients. VATS demonstrates particular utility during the fibrinopurulent stage. No single fibrinolytic agent has demonstrated clear superiority; however, tissue plasminogen activator is most widely employed. Open decortication remains reserved for refractory or advanced-stage disease. Conclusion: Early diagnosis, appropriate antibiotics, and prompt intervention or surgery are all important for optimal care. The optimal outcomes require a multidisciplinary, individualized, stage-directed approach. Interventional radiology is appropriate for single loculations, while early VATS is favored for thick pleural rind or multiple loculations. Further high-quality prospective research is needed to establish definitive treatment algorithms.
Introduction: Developmental dyslexia refers to a common neurodevelopmental disorder, which impairs the accuracy and fluency of reading, and early identification is vital for initiating timely intervention. Nonetheless, the traditional methods of formal assessment are time- and resource-intensive, which limits their scalability. Machine-learning approaches and eye-tracking technologies provide objective, data-driven solutions for dyslexia screening. This research integrates current evidence on eye-movement-based and emerging multimodal computational methods for dyslexia screening, risk identification, and algorithmic classification during reading tasks. Methods: PubMed, Scopus, Web of Science, and CINAHL were searched systematically to identify studies published between January 2015 and March 2026. Eligible studies included analysis of eye-movement obtained via eye tracking or electrooculography (EOG), with or without predictive modeling. Methodological quality was assessed using JBI, PROBAST, ROBINS-I, and COSMIN tools. Results: = 2). The sample sizes ranged from small experimental cohorts (<20 participants) to larger datasets (>300 participants). In the literature, dyslexic readers were consistently found to exhibit longer fixation durations, increased regression behavior and reduced saccadic efficiency. Machine-learning algorithms using fixation, saccade, scan path, and signal-based features demonstrated classification accuracies ranging from approximately 80 to 95% with some studies reporting values approaching 99% under specific experimental conditions. Discussion: Nevertheless, there was a significant heterogeneity in datasets, feature extraction methods, outcome definitions and validation schemes. Notably, numerous studies used proxy diagnostic labels, small or internally derived datasets, and internal cross-validation, which introduces the risk of overfitting and performance inflation. Explicit multimodal or multi-source modeling was identified in three of 23 studies involving combinations of gaze data with demographic, cognitive, linguistic, VR-bed, text-derived, saliency-map, or CNN-based features. Two additional studies used EOG as an alternative eye-movement signal modality rather than true multi-source fusion. Therefore, the evidence base remains dominated by eye-movement and gaze-derived approaches, while multimodal evidence should be interpreted as emerging and exploratory. Altogether, eye-movement based computational systems are a promising, non-invasive method for scalable dyslexia screening. Systematic review registration: PROSPERO, identifier (RD42061332527).
Temporal Lobe Epilepsy (TLE), a very common type of focal epilepsy, requires early and precise identification to enable prompt treatment and enhance patient outcomes. Traditional methods of detection, most notably manual MRI interpretation, tend to be time-consuming, subjective, and dependent on expert specialists, hindering their scalability and reliability. Due to the limitations of conventional and current automated systems—e.g., poor feature extraction, poor segmentation, and low accuracy in classification—this work presents NeuroTLEDNet, a new end-to-end artificial intelligence model for early TLE detection from medical images. The new methodology integrates multiple series of innovations across every processing phase. In preprocessing, skull stripping, Gaussian blurring, and color normalization are used to improve image uniformity and suppress irrelevant structures. In segmentation, the improved TLE-SegNet + is suggested—based on Mask R-CNN and supplemented with DarkNet-53, DenseNet, HetConv layers, and Attention Feature Pyramid Networks (FPN)—to facilitate highly accurate delineation of epileptogenic areas. For further describing the segmented areas, a rich feature space encompassing color histograms, Local Binary Patterns (LBP), and geometric features (eccentricity, area, perimeter) is developed. To resolve inefficiencies in feature selection, this paper presents the Squirrel Reptilian Optimization (SRO) algorithm, a new hybrid metaheuristic that incorporates both the Squirrel Search Algorithm (SSA) and the Reptile Search Algorithm (RSA). The hybrid enhances discriminative feature selection by handling exploration and exploitation dynamics better compared to individual methods. For categorization, NeuroTLEDNet utilizes an in-depth hybrid ensemble of 3D Convolutional Neural Networks (3D-CNN), Recurrent Neural Networks (RNN), Radial Basis Function Networks (RBFN), and SqueezeNet, facilitating powerful modeling of spatial-temporal relationships in brain MRI scans. Tested on an 80/30 split MRI dataset, the designed model attains a remarkable accuracy of 98.6%, outperforming current methods like CNN-LSTM (94.2%), Mask R-CNN (92.7%), and ResNet-based architectures (93.1%). Indeed, NeuroTLEDNet provides an end-to-end solution for the shortcomings of existing TLE detection methods by utilizing advanced preprocessing, segmentation, feature optimization, and hybrid classification, with state-of-the-art performance in terms of both accuracy and explainability. The suggested model is a promising candidate for clinical application, and it has the potential to assist neurologists in faster and more accurate TLE diagnosis.
Background/Objectives: The earlier, more accurate, and more consistent prediction of the brain tumor recognition process requires automated systems to minimize diagnostic delays and human error. The automated system provides a platform for handling large medical images, speeding up clinical decision-making. However, the existing system is facing difficulties due to the high variability in tumor location, size, and shape, which leads to segmentation complexity. In addition, glioma-related tumors infiltrate the brain tissues, making it challenging to identify the exact tumor region. Method: The above-identified research difficulties are overcome by applying the Swin-UNet with cuttlefish-optimized attention-based Graph Neural Networks (SCAG-Net), thereby improving overall brain tumor recognition accuracy. This integrated approach is utilized to address infiltrative gliomas, tumor variability, and feature redundancy issues by improving diagnostic efficiency. Initially, the collected MRI images are processed using the Swin-UNet approach to identify the region, minimizing prediction error robustly. The region’s features are explored utilizing the cuttlefish algorithm, which minimizes redundant features and speeds up classification by improving accuracy. The selected features are further processed using the attention graph network, which handles structural and heterogeneous information across multiple layers, improving classification accuracy compared to existing methods. Results: The efficiency of the system, implemented with the help of public datasets such as BRATS 2018, BRATS 2019, BRATS 2020, and Figshare is ensured by the proposed SCAG-Net approach, which achieves maximum recognition accuracy. The proposed system achieved a Dice coefficient of 0.989, an Intersection over Union of 0.969, and a classification accuracy of 0.992. This performance surpassed the most recent benchmark models by margins of 1.0% to 1.8% and with statistically significant differences (p < 0.05). These findings present a statistically validated, computationally efficient, clinically deployable framework. Conclusions: The effective analysis of MRI complex structures is used in medical applications and clinical analysis. The proposed SCAG-Net framework significantly improves brain tumor recognition by addressing tumor heterogeneity and infiltrative gliomas using MRI images. The proposed approach provides a robust, efficient, and clinically deployable solution for brain tumor recognition from MRI images, supporting accurate and rapid diagnosis while maintaining expert-level performance.
In the present scenario, cancerous tumours are common in humans due to major changes in nearby environments. Skin cancer is a considerable disease detected among people. This cancer is the uncontrolled evolution of atypical skin cells. It occurs when DNA injury to skin cells, or a genetic defect, leads to an increase quickly and establishes malignant tumors. However, in rare instances, many types of skin cancer occur from DNA changes tempted by infrared light affecting skin cells. This disease is a worldwide health problem, so an accurate and appropriate diagnosis is needed for efficient treatment. Current developments in medical technology, like smart recognition and analysis utilizing machine learning (ML) and deep learning (DL) techniques, have transformed the analysis and treatment of these conditions. These approaches will be highly effective for the recognition of skin cancer utilizing biomedical imaging. This study develops a Multi-scale Feature Fusion of Deep Convolutional Neural Networks on Cancerous Tumor Detection and Classification (MFFDCNN-CTDC) model. The main aim of the MFFDCNN-CTDC model is to detect and classify cancerous tumours using biomedical imaging. To eliminate unwanted noise, the MFFDCNN-CTDC method initially utilizes a sobel filter (SF) for the image preprocessing stage. For the segmentation process, Unet3+ is employed, providing precise localization of tumour regions. Next, the MFFDCNN-CTDC model incorporates multi-scale feature fusion by combining ResNet50 and EfficientNet architectures, capitalizing on their complementary strengths in feature extraction from varying depths and scales of the input images. The convolutional autoencoder (CAE) model is utilized for the classification method. Finally, the parameter tuning process is performed through a hybrid fireworks whale optimization algorithm (FWWOA) to enhance the classification performance of the CAE model. A wide range of experiments is performed to authorize the performance of the MFFDCNN-CTDC approach. The experimental validation of the MFFDCNN-CTDC approach exhibited a superior accuracy value of 98.78% and 99.02% over existing techniques under ISIC 2017 and HAM10000 datasets.
skin cancer detectionskin lesion classificationmulti-scale feature fusionconvolutional neural networks
The recent approval of the nasal spray combination of mometasone (MOM) and olopatadine (OLO) presents a significant analytical challenge, as only a single reported method exists for its determination, deviating from eco-friendly practices. This study addresses this critical gap by pioneering the application of machine learning techniques to develop robust UV spectrophotometric approach for the simultaneous quantification of MOM and OLO, along with two genotoxic impurities: 4-dimethylamino pyridine (DAP) and methyl para-toluene sulfonate (MTS). By simultaneously determining these highly concerning genotoxic impurities and active pharmaceutical ingredients, this method underscores its paramount significance in upholding rigorous pharmaceutical quality standards and safeguarding patient safety. Applying the multilevel-multifactor experimental design, the calibration set was meticulously chosen at five different concentrations, yielding 25 calibration mixtures with central levels of 4, 46.5, 2.5, and 3 µg/mL for MOM, OLA, MTS, and DAP, respectively. The key innovation lies in the strategic implementation of the Kennard-Stone Clustering Algorithm to create a robust validation set of thirteen mixtures, resolving the limitations of reported chemometric methods' random data splitting. This approach ensures unbiased evaluation across the full concentration space, improving the method's reliability and sustainability. The robustness of this approach was rigorously tested using five distinct chemometric models: principal component regression, classical least squares, partial least squares, genetic algorithm-partial least squares, and multivariate curve resolution-alternating least squares, demonstrating its broad applicability across diverse modeling techniques. All models successfully determined all components with excellent recovery, low bias-corrected prediction, and adequate limits of detection. The Greenness Index Spider Charts and the Green Solvents Selection Tool were used to choose environmentally conscious solvents. A comprehensive sustainability assessment employed six state-of-the-art tools, including the national environmental method index, complementary green analytical procedure index, analytical greenness metric, blue applicability grade index, carbon footprint analysis, and the red-green-blue 12 metrics. Favorable results across all metrics affirmed the method's eco-friendliness, real-world applicability, and cost-effectiveness, supporting sustainable development goals in pharmaceutical quality control processes.
The ADHD detector analyzes behavioral, cognitive, or physiological data (e.g., EEG, eye-tracking, or surveys) to identify patterns associated with ADHD symptoms. This work offers a more sophisticated method of detecting ADHD by overcoming the main drawbacks of existing approaches in terms of data processing, detection accuracy, and computational time. The work is inspired by the fact that Deep Learning (DL) frameworks could transform the existing detection systems of ADHD. In the proposed framework, there is a new NeuroDCT-ICA module for the preprocessing of raw EEG data, which guarantees the elimination of noise and extraction of informative features. Moreover, the method introduces a novel RhinoFish Optimization (RFO) algorithm for selecting optimal features, which enhance the data processing capacity and the stability of the system. As a core of the approach, there is the ADHD-AttentionNet - the deep learning-based model aimed at improving the accuracy and confidence of ADHD identification. The model is validated with the standard metrics, and the performance of the model is outstanding as it has high accuracy of 98.52%, F-score of 98.26% and specificity of 98.16%. These outcomes show that the proposed model yields better accuracy in detecting ADHD related patterns.
Congenital heart disease (CHD), impacting around 1 % of infants worldwide, constitutes a significant healthcare challenge. Early detection is crucial, however constrained by the intricacies of conventional diagnostic techniques such as auscultation and echocardiography. This research presents a tailored one-dimensional convolutional neural network (1D-CNN) for the classification of phonocardiogram (PCG) signals into normal or abnormal categories, providing an automated and efficient solution for congenital heart disease (CHD) diagnosis. The model was trained on a composite dataset consisting of local pediatric PCG signals and publicly accessible dataset. Preprocessing methods, such as low- and high-pass filtering (60-650 Hz), resampling, and noise reduction, were utilized to enhance signal quality. Data augmentation techniques, including chunking, padding, and pitch-shifting, were employed to rectify dataset imbalances and improve model efficacy. Experimental results indicate substantial enhancements, attaining an accuracy of 98.56 %, precision of 98.56 %, F1 score of 98.55 %, sensitivity of 0.98, and specificity of 0.99. The comparative analysis demonstrates the proposed approach's superiority over current methods regarding accuracy and reliability. The research highlights the promise of combining modern signal processing with deep learning for efficient CHD screening. The suggested model exhibits outstanding performance yet, issues like dataset variability and noise persist. Future endeavors involve extending to multiclass categorization and assessing performance across a wider range of medical problems. This study represents a significant advancement in accessible, automated CHD diagnoses, enhancing clinical competence to elevate pediatric treatment.